Shannon Medley
Medical · Edmond, OKNPI 1376705806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 218 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,760 and has fallen 82.6% since, to $307 in 2025.
Across 218 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$422
- Amgen$325
- Novo Nordisk$297
- Astellas Pharma US Inc$290
- Lilly USA, LLC$233
- GSK$206
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,223100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $422 |
| Amgen(2 entities) | 23 | $325 |
| Novo Nordisk | 24 | $297 |
| Astellas Pharma US Inc | 15 | $290 |
| Lilly USA, LLC | 18 | $233 |
| GSK | 20 | $206 |
| Boehringer Ingelheim | 15 | $205 |
| Merck | 14 | $196 |
| AstraZeneca | 8 | $164 |
| Biohaven Pharmaceuticals, Inc. | 2 | $129 |
| Nevro Corp. | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| Pfizer | 4 | $56 |
| Amarin Pharma, Inc. | 3 | $52 |
| Medtronic | 2 | $44 |
| Abbott | 2 | $41 |
| Globus Medical | 2 | $40 |
| Genentech USA, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $36 |
| Saluda Medical Americas, Inc. | 1 | $30 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Novartis | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
| Alnylam Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$114
How this compares
$3,223 in reported general payments places this provider in the 80th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 63 | $1,056 |
| Tizanidine Hcl | 28 | $487 |
| Baclofen | 14 | $0 |
Paid to pharmacies, not to this prescriber.
Other medical in Edmond
- Elizabeth MontgomeryEdmond$9K
- Amelia MonchoEdmond$7K
- Amber WellmanEdmond$5K
- Crystal FredricksonEdmond$5K
- Bethany TrianaEdmond$4K
- Karlee PfaffEdmond$3K
- Mebin ThomasOklahoma City$323K
- Kelle ChristiansonMidwest City$117K
- Kristine MurrowOklahoma City$81K
- Matthew DohlmanTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.